Starting a new anti‐seizure medication in drug‐resistant epilepsy: Add‐on or substitute?

MLA

Janmohamed, Mubeen, et al. “Starting a New Anti‐seizure Medication in Drug‐resistant Epilepsy: Add‐on or Substitute?” Epilepsia (Series 4), vol. 62, no. 1, Jan. 2021, pp. 228–37. EBSCOhost, https://doi.org/10.1111/epi.16765.

APA

Janmohamed, M., Lawn, N., Spilsbury, K., Chan, J., & Dunne, J. (2021). Starting a new anti‐seizure medication in drug‐resistant epilepsy: Add‐on or substitute? Epilepsia (Series 4), 62(1), 228–237. https://doi.org/10.1111/epi.16765

Chicago

Janmohamed, Mubeen, Nicholas Lawn, Katrina Spilsbury, Josephine Chan, and John Dunne. 2021. “Starting a New Anti‐seizure Medication in Drug‐resistant Epilepsy: Add‐on or Substitute?” Epilepsia (Series 4) 62 (1): 228–37. doi:10.1111/epi.16765.